Intracellular CYTL1, a Novel Tumor Suppressor, Stabilizes NDUFV1 to Inhibit Metabolic Reprogramming in Breast Cancer

Researchers demonstrated that intracellular cytokine-like protein 1 (CYTL1) played a key role in preventing the robust glycolytic switching characteristics of breast cancer.